{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:25:41Z","timestamp":1777555541590,"version":"3.51.4"},"reference-count":11,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Emerg Med J"],"accepted":{"date-parts":[[2013,11,23]]},"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To establish the safety of an intranasal diamorphine (IND) spray in children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>An open-label, single-dose pharmacovigilance trial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Emergency departments in eight UK hospitals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Children aged 2\u201316\u2005years with a fracture or other trauma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcome measures<\/jats:title><jats:p>Adverse events (AE) specifically related to nasal irritation, respiratory and central nervous system depression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>226 patients received 0.1\u2005mg\/kg IND. No serious or severe AEs occurred. The incidence of treatment-emergent AEs (TEAEs) was 26.5% (95% CI 20.9% to 32.8%), 93% being mild. 89% were related to treatment, all being known effects of the drug or route of administration except for three events in two patients. 20.4% (95% CI 15.3% to 26.2%) patients reported nasal irritation, all mild except one moderate and one \u2018unknown\u2019 severity. No respiratory depression was reported. Three AEs related to reduced Glasgow Coma Score (GCS) occurred, all mild.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There were no safety concerns raised during the conduct of the study. In addition to expected side effects, IND can cause mild nasal irritation in a proportion of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>European Union Drug Regulating Authorities Clinical Trial No<\/jats:title><jats:p>2009-014982-16.<\/jats:p><\/jats:sec>","DOI":"10.1136\/emermed-2013-203226","type":"journal-article","created":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T03:21:54Z","timestamp":1389324114000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["A novel multipatient intranasal diamorphine spray for use in acute pain in children: pharmacovigilance data from an observational study"],"prefix":"10.1136","volume":"32","author":[{"given":"Jason","family":"Kendall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Maconochie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C K","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"2024052700512945000_32.4.269.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_233.x"},{"key":"2024052700512945000_32.4.269.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408233110812"},{"key":"2024052700512945000_32.4.269.3","doi-asserted-by":"publisher","DOI":"10.1136\/emj.14.2.70"},{"key":"2024052700512945000_32.4.269.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7281.261"},{"key":"2024052700512945000_32.4.269.5","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2009.072538"},{"key":"2024052700512945000_32.4.269.6","doi-asserted-by":"publisher","DOI":"10.2174\/157339610793743903"},{"key":"2024052700512945000_32.4.269.7","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2006.034140"},{"key":"2024052700512945000_32.4.269.8","unstructured":"College of Emergency Medicine Clinical Effectiveness Committee. Guideline for the management of pain in children. May 2010. http:\/\/www.collemergencymed.ac.uk\/Shop-Floor\/Clinical%20Guidelines\/Clinical%20Guidelines\/default.asp (accessed 2 Jul 2013)."},{"key":"2024052700512945000_32.4.269.9","unstructured":"Advanced Life Support Group. Advanced Paediatric Life Support: the Practical Approach (APLS). 5th edn. BMJ Books, 2011:310."},{"key":"2024052700512945000_32.4.269.10","unstructured":"British National Formulary for Children. The essential resource for clinical use of medicines in children. BMJ Group RPS Publishing RCPCH Publications Ltd, 2011."},{"key":"2024052700512945000_32.4.269.11","unstructured":"Unreported data: Randomised, controlled, one-way blinded multicentre study comparing nasal diamorpine hydrochloride with intramuscular morphine sulpate for emergency analgesia in children presenting to the A&E department with clinical fractures. Wockhardt UK Ltd (CP Pharmaceuticals). 1999."}],"container-title":["Emergency Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/emermed-2013-203226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:51:39Z","timestamp":1716796299000},"score":1,"resource":{"primary":{"URL":"https:\/\/emj.bmj.com\/lookup\/doi\/10.1136\/emermed-2013-203226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":11,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,3,24]]},"published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1136\/emermed-2013-203226"],"URL":"https:\/\/doi.org\/10.1136\/emermed-2013-203226","relation":{},"ISSN":["1472-0205","1472-0213"],"issn-type":[{"value":"1472-0205","type":"print"},{"value":"1472-0213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}